You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0100 In early inflammatory arthritis a lymphoid pathotype signficantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort (PEAC)

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
THU0100 In early inflammatory arthritis a lymphoid pathotype signficantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort (PEAC)
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lliso-Ribera G, Humby F, Kelly S, et al
THU0100 In early inflammatory arthritis a lymphoid pathotype signficantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort (PEAC)
Annals of the Rheumatic Diseases 2017;76:238.